Consistency and affordability are the hallmarks of our generic portfolio. We ensure that our generic medicines are bioequivalent to innovator brands while remaining accessible to global markets.
At Rovantus, 'Generic' does not mean a compromise on quality. We apply the same rigorous QA/QC standards to our generics as we do to our specialized portfolios, ensuring global health equity.

